Associations between Later‐life Cerebrovascular Reactivity and Brain Structure and Cognitive Decline: A Longitudinal Study in an Aging Cohort with Varying Dementia Risks

Abstract Background Cerebrovascular reactivity (CVR) is implicated in the progression of dementia, though the underlying mechanisms is not understood. This study examines the relationships between CVR and brain structure and cognitive decline, moderated by mid‐life dementia risk. Method 163 participants from the Whitehall‐II cohort underwent neuropsychological testing and MRI, including T1‐weighted, FLAIR, and DTI sequences, at two phases (Phase‐I: mean age=68.2±4.4; Phase‐II: mean age=76.9±4.5). CVR was quantified via BOLD response to 5% CO 2 only at Phase‐II. Linear regression tested the Phase‐II and Phase‐I to Phase‐II associations between CVR and brain and cognitive outcomes (Table 1), alongside its interaction with dementia risks. Post‐hoc analysis clarified the extent of these associations among different risk groups. Result Tables 2 and 3 list significant cross‐sectional and longitudinal results, respectively. At Phase‐II, global CVR was positively associated with volume of left nucleus accumbens, and temporoparietal junction (p<0.03). Parietal CVR was positively associated with left hippocampus volume (p=0.03). These associations were more pronounced in the low‐risk group. Temporal CVR was related to thalamus volume (p<0.05) across all participants, with associations of the right thalamus exclusive to the high‐risk group (p=0.03). Longitudinally, lower global and regional CVR at Phase‐II was linked to greater reduction in temporoparietal junction volume (p<0.04). In high‐risk individuals, lower frontal, parietal, or global CVR was linked to larger volume declines in total grey matter or right thalamus respectively (p<0.05). Across all participants, lower parietal CVR at follow‐up was linked to greater FA reductions and RD increases between examinations in the corpus callosum (p=0.02) and to greater declines in FA and increases in MD, RD, and L1 in the cingulum bundle (p<0.04), with these effects being more pronounced in the low‐risk group. At Phase‐II, lower parietal and temporal CVR was associated with worse fluency and intelligence, respectively, in high‐risk individuals (p<0.05). Lower frontal CVR was linked to more executive function decline in the low‐risk group over‐time (p=0.03). Conclusion This study highlights the differential impacts of global and regional CVR on brain structure and cognitive changes dependent on mid‐life dementia risks, which provides evidence for CVR as a potential biomarker for dementia and age‐related cognitive change.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.092261
Primary Topic
Neurological Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations between Later‐life Cerebrovascular Reactivity and Brain Structure and Cognitive Decline: A Longitudinal Study in an Aging Cohort with Varying Dementia Risks

G. D. F. Reid, Raihaan Patel, Sana Suri, Daniel P. Bulte et al.
Alzheimer s & Dementia
Neurological Disease Mechanisms and Treatments
article

Associations between Later‐life Cerebrovascular Reactivity and Brain Structure and Cognitive Decline: A Longitudinal Study in an Aging Cohort with Varying Dementia Risks

G. D. F. Reid, Raihaan Patel, Sana Suri, Daniel P. Bulte, Clare E. Mackay, Mika Kivimaki B, Congxiyu Wang, Archana Singh‐Manoux, Georgina Hobden, Klaus P. Ebmeier, Lucy Jobbins
article en

Abstract

Abstract Background Cerebrovascular reactivity (CVR) is implicated in the progression of dementia, though the underlying mechanisms is not understood. This study examines the relationships between CVR and brain structure and cognitive decline, moderated by mid‐life dementia risk. Method 163 participants from the Whitehall‐II cohort underwent neuropsychological testing and MRI, including T1‐weighted, FLAIR, and DTI sequences, at two phases (Phase‐I: mean age=68.2±4.4; Phase‐II: mean age=76.9±4.5). CVR was quantified via BOLD response to 5% CO 2 only at Phase‐II. Linear regression tested the Phase‐II and Phase‐I to Phase‐II associations between CVR and brain and cognitive outcomes (Table 1), alongside its interaction with dementia risks. Post‐hoc analysis clarified the extent of these associations among different risk groups. Result Tables 2 and 3 list significant cross‐sectional and longitudinal results, respectively. At Phase‐II, global CVR was positively associated with volume of left nucleus accumbens, and temporoparietal junction (p<0.03). Parietal CVR was positively associated with left hippocampus volume (p=0.03). These associations were more pronounced in the low‐risk group. Temporal CVR was related to thalamus volume (p<0.05) across all participants, with associations of the right thalamus exclusive to the high‐risk group (p=0.03). Longitudinally, lower global and regional CVR at Phase‐II was linked to greater reduction in temporoparietal junction volume (p<0.04). In high‐risk individuals, lower frontal, parietal, or global CVR was linked to larger volume declines in total grey matter or right thalamus respectively (p<0.05). Across all participants, lower parietal CVR at follow‐up was linked to greater FA reductions and RD increases between examinations in the corpus callosum (p=0.02) and to greater declines in FA and increases in MD, RD, and L1 in the cingulum bundle (p<0.04), with these effects being more pronounced in the low‐risk group. At Phase‐II, lower parietal and temporal CVR was associated with worse fluency and intelligence, respectively, in high‐risk individuals (p<0.05). Lower frontal CVR was linked to more executive function decline in the low‐risk group over‐time (p=0.03). Conclusion This study highlights the differential impacts of global and regional CVR on brain structure and cognitive changes dependent on mid‐life dementia risks, which provides evidence for CVR as a potential biomarker for dementia and age‐related cognitive change.

Alzheimer s & DementiaVol. 20(S2)
University of Helsinki (FI), Inserm (FR), Université Paris Cité (FR), University of Oxford (GB), Wellcome Centre for Integrative Neuroimaging (GB), University College London (GB)
Engineering and Physical Sciences Research Council
Openalex Percentile: Top 71%
Neurological Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.